Skip to main content
    C

    Co-Diagnostics, Inc. Common Stock (CODX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.20
    -0.03 (-12.85%)

    Market Cap: $2.72M

    Last updated: Nov 17, 2026 at 4:39 PM ET

    Co-Diagnostics, Inc. Common Stock (CODX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Co-Diagnostics, Inc. Common Stock (CODX) has a market cap of $2.72M and an enterprise value of $2.00M. It kept -5527.61% of revenue as net income over the last 12 months. Revenue grew 69.11% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 26.29% below the market cap, as cash exceeds debt.

    Market Cap$2.72M
    Enterprise Value$2.00M
    Latest price (Nov 17, 2026)$0.20

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 45.54% in the quarter ended Sep 30, 2026.

    Shares Outstanding6.27M
    Shares Change (QoQ)+45.54%

    Valuation Ratios

    Sales and book value multiples are 1.4x and 0.1x. Its year-end P/S ranged from 2.4x to 81.6x from 2019 to 2025.

    P/S Ratio1.4x
    Forward P/S4.2x
    P/B Ratio0.1x
    P/TBV Ratio0.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 98.03% over 52 weeks and trades 73.68% below its 50-day average.

    Beta (1Y)2.57
    52-Week Change-98.03%
    1-Month Change-70.57%
    3-Month Change-82.18%
    6-Month Change-90.05%
    5-Year Change-99.85%
    Total Return (1Y)-98.03%
    Total Return (3Y CAGR)-83.20%
    Total Return (5Y CAGR)-76.51%
    Max Drawdown (1Y)-98.31%
    Max Drawdown (3Y)-99.63%
    Sharpe Ratio (1Y)-1.93
    Correlation with SPY (1Y)0.17
    50-Day Average$0.76
    200-Day Average$2.05
    52-Week Range$0.22 to $13.54
    RSI (14 Days)20.6
    Average Volume (20 Days)5.67M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.77x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.77x
    Quick Ratio0.50x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -503.71% over the last 12 months, against a 5-year average of -64.69%.

    Return on Equity (ROE)-503.71%
    Return on Assets (ROA)-371.14%
    ROE (5Y Average)-64.69%
    ROA (5Y Average)-54.90%
    Asset Turnover0.03x
    Inventory Turnover0.90x
    Receivables Turnover16.54x
    Cash Conversion Cycle-111 days

    Scores

    CODX has an Altman Z-Score of -23.38, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-23.38
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $858.89K over the last 12 months.

    Revenue$858.89K
    Revenue Growth (YoY)+69.11%
    Gross Profit$174.08K
    Operating Income-$48.22M
    Pretax Income-$47.93M
    Net Income-$47.48M
    EBITDA-$47.28M
    Reported EPS (TTM)-$11.00

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 73.73% of the $12.79M in total assets.

    Cash and Equivalents$714.80K
    Total Debt$0
    Net Cash$714.80K
    Net Cash Per Share$0.11
    Working Capital-$573.72K
    Shareholder Equity$9.43M
    Book Value Per Share$1.50
    Tangible Book Value$2.21M
    Tangible Book Per Share$0.35
    Total Assets$12.79M
    Total Liabilities$3.37M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $307.27K of capital spending, operating cash flow left -$27.19M of free cash flow.

    Operating Cash Flow-$26.88M
    Capital Expenditures$307.27K
    Free Cash Flow-$27.19M
    FCF Per Share-$3.08
    Depreciation and Amortization$947.21K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5614.27%.

    Gross Margin20.27%
    Operating Margin-5614.27%
    Pretax Margin-5580.41%
    Net Margin-5527.61%
    EBITDA Margin-5504.44%
    FCF Margin-3165.71%
    Gross Margin (5Y Average)69.90%

    Growth

    Revenue fell 73.70% a year over 3 years.

    Revenue Growth (3Y CAGR)-73.70%
    Revenue Growth (5Y CAGR)-61.60%

    Revenue and profit by year

    Dividends and Yields

    CODX does not pay a dividend. Its free cash flow yield is -2211.57%.

    FCF Yield-2211.57%
    Buyback Yield-1366.13%
    Shareholder Yield-1366.13%

    Stock Splits

    The last split was a 1-for-30 reverse split on Jan 2, 2026.

    Last Split DateJan 2, 2026
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 7 similar companies, CODX has the 3rd highest P/S.

    P/S Ratio1.4x vs 0.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+69.11% vs +27.56% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 427.30% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+427.30%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CODX

    What is CODX's market cap?

    Co-Diagnostics, Inc. Common Stock has a market cap of $2.72M. Its enterprise value, which adds debt and subtracts cash, is $2.00M.

    How many shares of CODX are outstanding?

    Co-Diagnostics, Inc. Common Stock has 6.27M shares outstanding.

    Does CODX pay a dividend?

    No. Co-Diagnostics, Inc. Common Stock does not pay a dividend.

    How much debt does CODX have?

    Co-Diagnostics, Inc. Common Stock has $0 of total debt and $714.80K of cash and equivalents, a net cash position of $714.80K.